YKYoshito Kamijo

Yoshito Kamijo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yoshito Kamijo has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Multicenter Retrospective Survey of Poisoning after Consumption of Products Containing Synthetic Chemicals in Japan

    by Yoshito Kamijo, Michiko Takai, Yuji Fujita, Yasuo Hirose, Yasumasa Iwasaki, Satoshi Ishihara, Takashi Yokoyama, Keiichi Yagi, Tetsuya Sakamoto

    Objective We conducted a multicenter retrospective survey of patients poisoned by synthetic chemicals (SCs) in Japan. Methods Letters were sent to 467 emergency facilities requesting participation in the study, and questionnaires were mailed to facilities that agreed to participate. Patients The study participants were patients who were transported to emergency facilities between January 2006 and December 2012 after consuming SC-containing products. Results We surveyed 518 patients from 60 (12.8%) facilities. Most patients were male (82.0%), in their 20s or 30s (80.5%), and had inhaled SCs (87.5%) contained in herbal products (86.0%). Harmful behavior was observed at the scene of poisoning for 56 patients (10.8%), including violence to others or things in 32, traffic accidents in seven, and self-injury or suicide attempts in four. Other than physical and neuropsychiatric symptoms, some patients also had physical complications, such as rhabdomyolysis (10.0%). Of the 182 patients (35.1%) admitted to hospitals, including 29 (5.6%) who needed respirators, all of the 21 (4.1%) hospitalized for at least seven days were male, and 20 had physical complications (rhabdomyolysis, 12; liver dysfunction, 5; renal dysfunction, 11; and physical injuries, 3). Most patients (95.6%) completely recovered, although 10 (1.9%) were transferred to a psychiatric department or hospital, and three (0.6%) were handed over to the police due to combative or violent behavior. SCs such as synthetic cannabinoids, synthetic cathinones, or methoxetamine were detected in 20 product samples. Conclusion Consuming products containing SCs can result in physical complications, including rhabdomyolysis, injuries, and physical or neuropsychiatric symptoms, which may require active interventions, such as respirator use or prolonged hospitalization.


  • A multicenter retrospective survey on a suicide trend using hydrogen sulfide in Japan

    by Yoshito Kamijo, Michiko Takai, Yuji Fujita, Yasuo Hirose, Yasumasa Iwasaki, Satoshi Ishihara

    Context. In Japan, suicide by inhaling hydrogen sulfide (H2S) by mixing commercial products escalated into a nationwide trend in April 2008. Objective. We conducted a multicenter retrospective survey on the demographics, clinical features, treatments, and outcomes of patients exposed to H2S suicide attempts. Materials and methods. Subjects included patients transported to emergency facilities in Japan from January 2005 to December 2011 following H2S suicide attempts. Among 277 facilities to which a letter requesting data collection was sent, questionnaires were sent to and filled out by the 47 (18%) facilities that agreed to provide data. Questionnaires were collected and data were extracted at Kitasato University. Results. A total of 156 patients were included in this survey. Patients involved in an H2S suicide attempt increased from 1 in 2007 to 51 in 2008, and gradually decreased from 44 in 2009 to 37 in 2010 and 23 in 2011. Ninety-two patients attempted H2S suicide (primary exposure group), and 64 were secondarily affected by the suicide attempt (secondary exposure group). Patients in the primary exposure group were young (mean, 30.3 years (10.9)), and male patients (n = 62) were approximately two times more likely to attempt H2S suicide than females (n = 30). Forty-eight patients in cardiopulmonary arrest at the scene did not survive. Five non-cardiopulmonary arrest patients died, and five patients who presented with a Glasgow coma scale (GCS) < 8 and lactic acidosis had neurological or cardiac signs or symptoms at discharge. Antidote therapy was performed on 26 of the primary group patients, but with poor outcomes. None of the secondary group patients were in cardiopulmonary arrest at the scene, five received antidotal therapy after arriving at the hospital, and all completely recovered from H2S exposure. Discussion and conclusion. Mortality (58%) among patients who attempted H2S suicide was very high, likely resulting from inhaling high concentrations of H2S after mixing commercial products in a sealed and confined space.


  • Severe carbon monoxide poisoning complicated by hypothermia: a case report

    by Yoshito Kamijo, Toshimitsu Ide, Ayako Ide, Kazui Soma


  • Open Access

    Notable Pink Excreta and Severe Myocardial Suppression in Superwarfarin (difethialone) Intoxication

    by Yoshito Kamijo, Chie Sato, Kuniko Yoshimura, Kazui Soma

    Patients rarely consult physicians before developing coagulopathy or bleeding in most reported cases of superwarfarin intoxication. A 57-year-old woman ingested red-dyed pellets of anticoagulant rodenticide containing difethialone and warfarin as well as tablets of nitrazepam. Although she presented to the hospital in a comatose state, notable pink-colored excreta hinted at the consumption of anticoagulant rodenticide, which led to the early diagnosis of superwarfarin intoxication. Supplementation of large doses of intravenous and oral vitamin K successfully prevented coagulopathy and bleeding. On the other hand, temporary and reversible myocardial suppression was extremely severe, and required the introduction of percutaneous cardiopulmonary support.


  • Open Access

    A randomized controlled multicenter trial of post-suicide attempt case management for the prevention of further attempts in Japan (ACTION-J)

    by Yoshio Hirayasu, Chiaki Kawanishi, Naohiro Yonemoto, Naoki Ishizuka, Yoshiro Okubo, Akio Sakai, Toshifumi Kishimoto, Hitoshi Miyaoka, Kotaro Otsuka, Yoshito Kamijo, et al.

    A previous suicide attempt is a potent risk factor for suicide later on. Crisis intervention, psychiatric and psychosocial evaluation at emergency medical facilities, and follow-up care for suicide attempters are considered important components for suicide prevention. The Japanese Multimodal Intervention Trials for Suicide Prevention (J-MISP) includes a randomized, controlled, multicenter trial of post-suicide attempt case management for the prevention of further attempts (ACTION-J) to address the continuing increase in suicides in Japan. The primary aim of ACTION-J is to examine the effectiveness of an extensive intervention for suicide attempters in prevention of recurrent suicidal behavior, as compared with standard intervention. This paper describes the rationale and protocol of the ACTION-J trial.


  • Effects of inhaled monoethanolamine on bronchoconstriction

    by Y. Kamijo, I. Hayashi, A. Ide, K. Yoshimura, K. Soma, M. Majima

    We previously reported a 65‐year‐old man who aspirated an alkaline detergent containing 3.3% w/v (weight of solute per volume of solution) monoethanolamine (MEA) into his lungs, causing asthma‐like symptoms. We presently describe the mechanism of MEA‐induced bronchoconstriction according to findings in guinea pigs. In anesthetized, artificially ventilated animals, changes in airway opening pressure (Pao) were measured as an index of bronchoconstriction. An aerosol of 3.3% MEA solution (0.1 ml kg−1) inhaled through a tracheal cannula induced significantly stronger bronchoconstriction than an aerosol of potassium hydroxide (KOH) solution (0.1 ml kg−1) at the same pH. MEA‐induced bronchoconstriction was significantly suppressed by premedication with intravenously injected atropine sulfate (3 mg kg−1), a muscarinic receptor antagonist, or diphenhydramine hydrochloride (10 mg kg−1), a histamine‐H1receptor antagonist. MEA‐induced bronchoconstriction was not enhanced by premedication with an intravenous injection of neostigmine (0.1 mg kg−1), an acetylcholinesterase inhibitor. When bronchoconstriction was induced by MEA, histamine concentrations in bronchoalveolar lavage fluid (BALF) were not significantly greater than in BALF after KOH‐induced bronchoconstriction or in BALF after inhalation of physiologic saline.In vitro, contraction of trachea denuded of epithelium during superfusion with MEA (10 mm) was suppressed by premedication with pyrilamine maleate, a histamine‐H1receptor antagonist, at 10 and 100 µm. Contraction of trachea denuded of epithelium during superfusion with MEA (10 mm) was suppressed by premedication with atropine sulfate at 10 and 100 µm. These results suggest that asthma‐like symptoms may result partly from agonistic MEA effects at histamine‐H1receptors and muscarinic receptors. Copyright © 2008 John Wiley & Sons, Ltd.


  • Open Access

    Fatal diphenhydramine poisoning with increased vascular permeability including late pulmonary congestion refractory to percutaneous cardiovascular support

    by Yoshito Kamijo, Kazui Soma, Chie Sato, Katsuyoshi Kurihara

    Background. Fatal adult cases of acute diphenhydramine poisoning are extremely rare. Case Report. Transiently awakened by a roommate, a 39-year-old man admitted to massive ingestion of an over-the-counter drug containing diphenhydramine salicylate. On admission the patient was semicomatose and developed circulatory collapse with severe dehydration and metabolic acidosis, followed by status epilepticus. Despite extensive life support measures including percutaneous cardiopulmonary support, vascular permeability progressively increased, with pulmonary congestion as well as peripheral vasodilation evident as rubedo. The patient died without improvement of cardiac function. Subsequent diphenhydramine assays in serum specimens obtained at the time of delayed congestive symptoms indicated decreases in drug concentration to a sublethal amount. Discussion. We suspect that metabolites of diphenhydramine with histamine-agonist actions contributed to the development of fatal delayed symptoms.


  • Gastric stenosis in severe corrosive gastritis: Prognostic evaluation by endoscopic ultrasonography

    by Yoshito Kamijo, Ichiei Kondo, Masaaki Watanabe, Tomomichi Kan'O, Ayako Ide, Kazui Soma

    Introduction. Endoscopic ultrasonography can provide high-resolution images of the gastric wall. Case Report. A 24-year-old woman with severe corrosive gastritis following massive ingestion of an alkaline household chemical was examined with endoscopic ultrasonography using a 20-MHz probe. Endoscopic ultrasonography disclosed diffuse thickening of the entire gastric wall and lack of demarcation of the muscular layer in the antrum. Several weeks after the ingestion, stenosis developed in the antrum and was treated with laparoscopic gastrectomy. Discussion. Endoscopic ultrasonography can provide accurate evaluation of depth of lesions in corrosive gastritis and may be useful in predicting gastric stenosis.


  • Open Access

    Pharmacokinetics of the Active Metabolites of Ethyl Loflazepate in Elderly Patients Who Died of Asphyxia Associated with Benzodiazepine-Related Toxicity

    by Yoshito Kamijo, Izumi Hayashi, Takashi Nishikawa, Kuniko Yoshimura, Kazui Soma

    We determined the pharmacokinetics of ethyl loflazepate (Lof) in elderly patients who died of benzodiazepine-related toxicity. Three elderly patients with body mass indexes of less than 17 kg/m2 died of asphyxia after having taken maintenance doses of Lof for 2 to 3 weeks. We measured serum concentrations of the active metabolites of Lof using gas chromatography-mass spectrometry and a benzodiazepine receptor assay to determine the pharmacokinetics of each. On admission, the serum concentrations of the active metabolites of Lof ([Lof]) were 256 ng/mL, 425 ng/mL, and 177 ng/mL in cases 1, 2, and 3, respectively. Serum benzodiazepine-receptor binding activities, expressed as diazepam equivalent concentrations ([Bz]), were 1800 ng/mL, 2200 ng/mL, and 1500 ng/mL. The T½(β) of [Lof] were 124 and 121 h in cases 1 and 2 and the T½(β) of [Bz] were 75 and 87 h. The distribution volume in the elderly was reduced due to a small lipid compartment, and total drug clearance was decreased due to the decline in liver and kidney function. These changes did not prolong T½(β) but did increase plasma concentrations of active metabolites, especially in case 2, and a slight decrease in protein binding increased the amount of free active metabolites greatly.